About this event
The Covid-19 crisis acted as a catalyst for investment in technology-led businesses in healthcare, with 2021 representing a high watermark for activity and valuations. The focus on asset-light and digitally-powered diminished in 2022 as pandemic restrictions started to subside but in the face of soaring costs, legacy infrastructure and politicized environments the market remains focused on introducing innovation to help address burgeoning global demand and faltering productivity.
In this webinar HolonIQ’s Health Intelligence Unit will review all deal activity in the first quarter of 2023, focusing on the distribution of investment capital globally and against the Global Healthcare Landscape Taxonomy.
The world's leading impact intelligence platform. Powering decisions that matter.
Share this event